<DOC>
	<DOC>NCT02720770</DOC>
	<brief_summary>This study evaluates the effect on height of a two year treatment with growth hormone in 19 children with X linked hypophosphatemic rickets.</brief_summary>
	<brief_title>Growth Hormone Treatment in Children With Hypophosphatemic Rickets</brief_title>
	<detailed_description />
	<mesh_term>Rickets</mesh_term>
	<mesh_term>Rickets, Hypophosphatemic</mesh_term>
	<mesh_term>Familial Hypophosphatemic Rickets</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>clinical, biochemical and genetic diagnosis of XLH height SDS &lt; 2 at least two years of treatment with oral phosphate and calcitriol uncontrolled rickets (ALP&gt;600 IU) growth hormone deficiency hyperparathyroidism, nephrocalcinosis, renal insufficiency associated disease previous treatment with growth hormone</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>growth hormone</keyword>
</DOC>